Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. SHL Telemedicine's shares outstanding for the quarter that ended in Dec. 2025 was 37.06 Mil.
SHL Telemedicine's quarterly shares outstanding
increased
from Jun. 2025 (29.80 Mil) to Dec. 2025 (37.06 Mil).
It means SHL Telemedicineissued new shares from Jun. 2025 to Dec. 2025 .
SHL Telemedicine's annual shares outstanding
increased
from Dec. 2024 (29.80 Mil) to Dec. 2025 (37.06 Mil).
It means SHL Telemedicineissued new shares from Dec. 2024 to Dec. 2025 .
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
SHL Telemedicine Shares Outstanding (EOP) Related Terms
SHL Telemedicine Shares Outstanding (EOP) Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHMLF vs VEEV, BTSG, TEM: Shares Outstanding (EOP) Comparison
For the Health Information Services subindustry, SHL Telemedicine's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Shares Outstanding (EOP) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 37.06 Mil mean?
SHL Telemedicine (SHMLF) has a Shares Outstanding (EOP) of 37.06 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on SHL Telemedicine and its competitors.
Is SHL Telemedicine's Shares Outstanding (EOP) too high?
SHL Telemedicine's current Shares Outstanding (EOP) is 37.06 Mil. Overall, SHL Telemedicine has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Shares Outstanding (EOP) compare to VEEV and BTSG?
SHL Telemedicine's Shares Outstanding (EOP) of 37.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on SHL Telemedicine and its competitors. SHL Telemedicine's current Shares Outstanding (EOP) is 37.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Shares Outstanding (EOP) of 37.06 Mil. The stock's GF Value™ is $13.95, compared to a current price of $4.84 — trading 65.3% below its estimated fair value. The current Shares Outstanding (EOP) is 37.06 Mil. SHL Telemedicine's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Shares Outstanding (EOP) is 37.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 65.3% below its estimated GF Value™ of $13.95.
Key valuation signals for SHMLF:
Shares Outstanding (EOP): 37.06 Mil
GF Value™: $13.95 vs. price of $4.84 (65.3% below fair value)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
51GF Score
Get the complete analysis for SHMLF
Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
